UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

__________________________________

Date of Report (Date of earliest event reported):  May 24, 2006

 

NEUROMETRIX, INC.

(Exact name of registrant as specified in charter)

Delaware

 

000-50856

 

04-3308180

(State or Other Jurisdiction

 

(Commission File Number)

 

(IRS Employer

of Incorporation)

 

 

 

Identification No.)

62 Fourth Avenue
Waltham, Massachusetts  02451
(Address of Principal Executive Offices)  (Zip Code)

(781) 890-9989
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 1.01            Entry Into a Material Definitive Agreement.

At the 2006 annual meeting of stockholders of NeuroMetrix, Inc. (the “Company”), on May 24, 2006, the Company’s stockholders approved an amendment to the Company’s Amended and Restated 2004 Stock Option and Incentive Plan (the “Plan”) that increased the total number of shares of common stock available for issuance under the Plan by 1,000,000 shares. The foregoing summary is qualified in its entirety by reference to the Plan, which is filed as Exhibit 99.1 to this Form 8-K and incorporated by reference.

Item 9.01.         Financial Statements and Exhibits.

(d)         Exhibits.

Exhibit No.

 

Description

99.1

 

Amended and Restated 2004 Stock Option and Incentive Plan (1)

(1)             Incorporated herein by reference to Appendix B to NeuroMetrix, Inc.’s Proxy Statement on Schedule 14A filed April 24, 2006 (File No. 000-50856).

2



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NEUROMETRIX, INC.

Dated: May 26, 2006

 

By:

/s/ Shai N. Gozani, M.D., Ph.D.

 

 

Shai N. Gozani, M.D., Ph.D.

 

 

President and Chief Executive Officer

 

3



EXHIBIT INDEX

Exhibit No.

 

Description

99.1

 

Amended and Restated 2004 Stock Option and Incentive Plan (1)

(1)             Incorporated herein by reference to Appendix B to NeuroMetrix, Inc.’s Proxy Statement on Schedule 14A filed April 24, 2006 (File No. 000-50856).

4